Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLICLAZIDE Cause Magnetic resonance imaging head abnormal? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Magnetic resonance imaging head abnormal have been filed in association with GLICLAZIDE. This represents 0.2% of all adverse event reports for GLICLAZIDE.

10
Reports of Magnetic resonance imaging head abnormal with GLICLAZIDE
0.2%
of all GLICLAZIDE reports
10
Deaths
8
Hospitalizations

How Dangerous Is Magnetic resonance imaging head abnormal From GLICLAZIDE?

Of the 10 reports, 10 (100.0%) resulted in death, 8 (80.0%) required hospitalization, and 8 (80.0%) were considered life-threatening.

Is Magnetic resonance imaging head abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLICLAZIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does GLICLAZIDE Cause?

Hypoglycaemia (756) Nausea (596) Acute kidney injury (553) Drug ineffective (507) Fall (415) Dyspnoea (400) Vomiting (385) Lactic acidosis (373) Malaise (360) Hypertension (351)

What Other Drugs Cause Magnetic resonance imaging head abnormal?

VIGABATRIN (187) OCRELIZUMAB (72) ADALIMUMAB (32) MYCOPHENOLATE MOFETIL (31) PREDNISOLONE (25) DEXAMETHASONE (24) CORTICOTROPIN (21) PREDNISONE (21) METHOTREXATE (17) RITUXIMAB (17)

Which GLICLAZIDE Alternatives Have Lower Magnetic resonance imaging head abnormal Risk?

GLICLAZIDE vs GLIMEPIRIDE GLICLAZIDE vs GLIMEPIRIDE\ROSIGLITAZONE GLICLAZIDE vs GLIPIZIDE GLICLAZIDE vs GLIVEC GLICLAZIDE vs GLOFITAMAB

Related Pages

GLICLAZIDE Full Profile All Magnetic resonance imaging head abnormal Reports All Drugs Causing Magnetic resonance imaging head abnormal GLICLAZIDE Demographics